Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer

Adjuvant hormonal therapy is one of the most important treatments of hormone-receptor-positive breast cancer and includes selective estrogen receptor modulators, aromatase inhibitors, and luteinizing hormone-releasing hormone analogs. In patients receiving these drugs, a progressive recession of fro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alfredo Rossi, Gemma Caro, Francesca Magri, Maria Caterina Fortuna, Marta Carlesimo
Formato: article
Lenguaje:EN
Publicado: Open Exploration Publishing Inc. 2021
Materias:
Acceso en línea:https://doaj.org/article/f128ca6dd8064316846e96e04b306f01
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f128ca6dd8064316846e96e04b306f01
record_format dspace
spelling oai:doaj.org-article:f128ca6dd8064316846e96e04b306f012021-11-08T10:10:44ZClinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer10.37349/etat.2021.000592692-3114https://doaj.org/article/f128ca6dd8064316846e96e04b306f012021-10-01T00:00:00Zhttps://www.explorationpub.com/Journals/etat/Article/100259https://doaj.org/toc/2692-3114Adjuvant hormonal therapy is one of the most important treatments of hormone-receptor-positive breast cancer and includes selective estrogen receptor modulators, aromatase inhibitors, and luteinizing hormone-releasing hormone analogs. In patients receiving these drugs, a progressive recession of frontal-temporal hairlines is often observed, such as a certain grade of hair miniaturization in the same areas and the central scalp area, producing a pseudo-female androgenic alopecia, which has to be considered oncotherapy-induced alopecia. The aim of this work, is to describe the clinical aspects and pathogenesis of this type of alopecia and to analyze the different drugs which have been proposed until now. The authors concude that topical hormones should not be considered as a therapeutic approach because of their direct or indirect oncogenic potential. A therapeutic approach that could be both safe and effective is proposed.Alfredo RossiGemma CaroFrancesca MagriMaria Caterina FortunaMarta CarlesimoOpen Exploration Publishing Inc.articlealopeciahormonal therapybreast cancerInternal medicineRC31-1245ENExploration of Targeted Anti-tumor Therapy, Vol 2, Iss 5, Pp 490-495 (2021)
institution DOAJ
collection DOAJ
language EN
topic alopecia
hormonal therapy
breast cancer
Internal medicine
RC31-1245
spellingShingle alopecia
hormonal therapy
breast cancer
Internal medicine
RC31-1245
Alfredo Rossi
Gemma Caro
Francesca Magri
Maria Caterina Fortuna
Marta Carlesimo
Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer
description Adjuvant hormonal therapy is one of the most important treatments of hormone-receptor-positive breast cancer and includes selective estrogen receptor modulators, aromatase inhibitors, and luteinizing hormone-releasing hormone analogs. In patients receiving these drugs, a progressive recession of frontal-temporal hairlines is often observed, such as a certain grade of hair miniaturization in the same areas and the central scalp area, producing a pseudo-female androgenic alopecia, which has to be considered oncotherapy-induced alopecia. The aim of this work, is to describe the clinical aspects and pathogenesis of this type of alopecia and to analyze the different drugs which have been proposed until now. The authors concude that topical hormones should not be considered as a therapeutic approach because of their direct or indirect oncogenic potential. A therapeutic approach that could be both safe and effective is proposed.
format article
author Alfredo Rossi
Gemma Caro
Francesca Magri
Maria Caterina Fortuna
Marta Carlesimo
author_facet Alfredo Rossi
Gemma Caro
Francesca Magri
Maria Caterina Fortuna
Marta Carlesimo
author_sort Alfredo Rossi
title Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer
title_short Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer
title_full Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer
title_fullStr Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer
title_full_unstemmed Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer
title_sort clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer
publisher Open Exploration Publishing Inc.
publishDate 2021
url https://doaj.org/article/f128ca6dd8064316846e96e04b306f01
work_keys_str_mv AT alfredorossi clinicalaspectpathogenesisandtherapyoptionsofalopeciainducedbyhormonaltherapyforbreastcancer
AT gemmacaro clinicalaspectpathogenesisandtherapyoptionsofalopeciainducedbyhormonaltherapyforbreastcancer
AT francescamagri clinicalaspectpathogenesisandtherapyoptionsofalopeciainducedbyhormonaltherapyforbreastcancer
AT mariacaterinafortuna clinicalaspectpathogenesisandtherapyoptionsofalopeciainducedbyhormonaltherapyforbreastcancer
AT martacarlesimo clinicalaspectpathogenesisandtherapyoptionsofalopeciainducedbyhormonaltherapyforbreastcancer
_version_ 1718442770274713600